Recall
FDAHealthDecember 16, 2025

SpecGx, LLC — Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. Case label: SpecGx LLC, NDC 0406052201, Exp. 20

⚠️ Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
December 16, 2025

Nationwide

What's affected?

Product
Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. Case label: SpecGx LLC, NDC 0406052201, Exp. 2027/03, Lot: 0522J23493
UPC
0304060522053
Lot code
0522J23493

Additional details

Lot: 0522J23493, expires: 03/2027.

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 74,544 bottles.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.